PURPLE ADVOCACY, LLC for DAVITA INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Veterans VET
Legislative provisions related to veteran dialysis facilities
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| MEGHAN JOHNSON | — |
Health Issues HCR
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. CMS regulations related to the treatment of Medicare Part C and D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| MEGHAN JOHNSON | — |
Medicare/Medicaid MMM
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. CMS regulations related to the treatment of Medicare Part C and D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| MEGHAN JOHNSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.